Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation

10.1371/journal.pone.0020226

Saved in:
Bibliographic Details
Main Authors: McMillin D.W., Delmore J., Negri J., Ooi M., Klippel S., Miduturu C.V., Gray N.S., Richardson P.G., Anderson K.C., Kung A.L., Mitsiades C.S.
Other Authors: MEDICINE
Format: Article
Published: 2019
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/162044
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-162044
record_format dspace
spelling sg-nus-scholar.10635-1620442024-05-08T09:51:25Z Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation McMillin D.W. Delmore J. Negri J. Ooi M. Klippel S. Miduturu C.V. Gray N.S. Richardson P.G. Anderson K.C. Kung A.L. Mitsiades C.S. MEDICINE 4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide polo like kinase 4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide caspase 3 cell cycle protein nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase oncoprotein polo like kinase 1 polo-like kinase 1 protein serine threonine kinase pteridine derivative animal experiment animal model article cell interaction controlled study drug mechanism enzyme activity enzyme inhibition human human cell in vitro study in vivo study mouse multiple myeloma nonhuman tumor microenvironment tumor xenograft bone cell cycle cell line cell survival coculture dose response drug antagonism drug effect drug screening IC 50 metabolism osteoclast pathology stroma cell time tumor cell line tumor microenvironment tumor volume Western blotting Blotting, Western Bone and Bones Caspase 3 Cell Cycle Cell Cycle Proteins Cell Line Cell Line, Tumor Cell Survival Coculture Techniques Dose-Response Relationship, Drug Humans Inhibitory Concentration 50 Multiple Myeloma Osteoclasts Poly(ADP-ribose) Polymerases Protein-Serine-Threonine Kinases Proto-Oncogene Proteins Pteridines Stromal Cells Time Factors Tumor Burden Tumor Microenvironment Xenograft Model Antitumor Assays 10.1371/journal.pone.0020226 PLoS ONE 6 7 e20226 2019-11-11T08:39:46Z 2019-11-11T08:39:46Z 2011 Article McMillin D.W., Delmore J., Negri J., Ooi M., Klippel S., Miduturu C.V., Gray N.S., Richardson P.G., Anderson K.C., Kung A.L., Mitsiades C.S. (2011). Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation. PLoS ONE 6 (7) : e20226. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0020226 19326203 https://scholarbank.nus.edu.sg/handle/10635/162044 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic 4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide
polo like kinase
4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide
caspase 3
cell cycle protein
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
oncoprotein
polo like kinase 1
polo-like kinase 1
protein serine threonine kinase
pteridine derivative
animal experiment
animal model
article
cell interaction
controlled study
drug mechanism
enzyme activity
enzyme inhibition
human
human cell
in vitro study
in vivo study
mouse
multiple myeloma
nonhuman
tumor microenvironment
tumor xenograft
bone
cell cycle
cell line
cell survival
coculture
dose response
drug antagonism
drug effect
drug screening
IC 50
metabolism
osteoclast
pathology
stroma cell
time
tumor cell line
tumor microenvironment
tumor volume
Western blotting
Blotting, Western
Bone and Bones
Caspase 3
Cell Cycle
Cell Cycle Proteins
Cell Line
Cell Line, Tumor
Cell Survival
Coculture Techniques
Dose-Response Relationship, Drug
Humans
Inhibitory Concentration 50
Multiple Myeloma
Osteoclasts
Poly(ADP-ribose) Polymerases
Protein-Serine-Threonine Kinases
Proto-Oncogene Proteins
Pteridines
Stromal Cells
Time Factors
Tumor Burden
Tumor Microenvironment
Xenograft Model Antitumor Assays
spellingShingle 4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide
polo like kinase
4 (8 cyclopentyl 7 ethyl 5,6,7,8 tetrahydro 5 methyl 6 oxo 2 pteridinylamino) 3 methoxy n (1 methyl 4 piperidinyl)benzamide
caspase 3
cell cycle protein
nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
oncoprotein
polo like kinase 1
polo-like kinase 1
protein serine threonine kinase
pteridine derivative
animal experiment
animal model
article
cell interaction
controlled study
drug mechanism
enzyme activity
enzyme inhibition
human
human cell
in vitro study
in vivo study
mouse
multiple myeloma
nonhuman
tumor microenvironment
tumor xenograft
bone
cell cycle
cell line
cell survival
coculture
dose response
drug antagonism
drug effect
drug screening
IC 50
metabolism
osteoclast
pathology
stroma cell
time
tumor cell line
tumor microenvironment
tumor volume
Western blotting
Blotting, Western
Bone and Bones
Caspase 3
Cell Cycle
Cell Cycle Proteins
Cell Line
Cell Line, Tumor
Cell Survival
Coculture Techniques
Dose-Response Relationship, Drug
Humans
Inhibitory Concentration 50
Multiple Myeloma
Osteoclasts
Poly(ADP-ribose) Polymerases
Protein-Serine-Threonine Kinases
Proto-Oncogene Proteins
Pteridines
Stromal Cells
Time Factors
Tumor Burden
Tumor Microenvironment
Xenograft Model Antitumor Assays
McMillin D.W.
Delmore J.
Negri J.
Ooi M.
Klippel S.
Miduturu C.V.
Gray N.S.
Richardson P.G.
Anderson K.C.
Kung A.L.
Mitsiades C.S.
Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation
description 10.1371/journal.pone.0020226
author2 MEDICINE
author_facet MEDICINE
McMillin D.W.
Delmore J.
Negri J.
Ooi M.
Klippel S.
Miduturu C.V.
Gray N.S.
Richardson P.G.
Anderson K.C.
Kung A.L.
Mitsiades C.S.
format Article
author McMillin D.W.
Delmore J.
Negri J.
Ooi M.
Klippel S.
Miduturu C.V.
Gray N.S.
Richardson P.G.
Anderson K.C.
Kung A.L.
Mitsiades C.S.
author_sort McMillin D.W.
title Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation
title_short Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation
title_full Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation
title_fullStr Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation
title_full_unstemmed Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: Implications for clinical translation
title_sort microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation
publishDate 2019
url https://scholarbank.nus.edu.sg/handle/10635/162044
_version_ 1800913832199061504